Clinical Trial Update: Pregabalin In Partial Seizures Extension Study [Phase 3]

View source ↗

Summary

A Phase 3 extension study of pregabalin in partial seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epileptic Seizures

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Seizures | Phase 3 | Status: COMPLETED